| Serial Number | 87660540 |
| Word Mark | GD3 |
| Filing Date | Thursday, October 26, 2017 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, July 25, 2025 |
| Registration Number | 5657219 |
| Registration Date | Tuesday, January 15, 2019 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 3, 2018 |
| Description of Mark | The mark consists of the literal element "GD3" where the letters "G" and "D" are depicted inside a bisected oblong shape representing a pill. The letter "G" is in white with an outline in various shades of red. The letter "D" is in white with an outline in various shades of grey. The left half of the pill design with the letter "G" is in various shades of red. The right side of the pill design with the letter "D" is in various shades of grey. The number "3" is depicted in red with a white outline inside a stylized depiction of a molecule located to the upper right of the "GD" lettering. The molecule consists of four gold spheres representing atoms, which are connected by three straight bands in various shades of grey representing bonds. |
| Pseudo Mark | GD THREE GENESIS DRUG DISCOVERY DEVELOPMENT |
| Indication of Colors claimed | The color(s) white, grey, red, and gold is/are claimed as a feature of the mark. |
| Goods and Services | Scientific study and research in the fields of medicine, the prevention and treatment of illness, drug screening, mode of action of medicines in animal models, and pharmacokinetic evaluation and preclinical evaluation of lead compounds in drug discovery |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, July 25, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, October 18, 2017 |
| First Use In Commerce Date | Tuesday, October 24, 2017 |
| Party Name | Genesis Drug Discovery & Development, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Hamilton, NJ 08690 |
| Party Name | Genesis Drug Discovery & Development, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Hamilton, NJ 08690 |
| Party Name | Genesis Drug Discovery & Development, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Hamilton, NJ 08690 |
| Event Date | Event Description |
| Saturday, November 4, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 30, 2017 | NEW APPLICATION ENTERED |
| Tuesday, November 7, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, February 6, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, February 20, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, February 20, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, February 27, 2018 | ASSIGNED TO LIE |
| Wednesday, March 14, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 3, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 20, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 20, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 20, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, November 27, 2018 | USE AMENDMENT FILED |
| Saturday, December 8, 2018 | STATEMENT OF USE PROCESSING COMPLETE |
| Saturday, December 8, 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, December 11, 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, January 15, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Friday, September 15, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, April 3, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 29, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 27, 2018 | TEAS STATEMENT OF USE RECEIVED |
| Saturday, December 8, 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, September 15, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, January 15, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, July 25, 2025 | CANCELLED SEC. 8 (6-YR) |
| Friday, September 15, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, September 15, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |